SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides

Condition:   Cutaneous T-Cell Lymphoma/Mycosis Fungoides Interventions:   Drug: Cobomarsen;   Drug: Vorinostat Sponsor:   miRagen Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials